Legal Briefs: Concordia/Par And FTC; Amgen Off-Label Compendium Settlement
Executive Summary
FTC objected to atypical Concordia deal with Par not to launch an authorized generic in return for share of profits on Par’s generic; Amgen settlement with 49 states restricts interactions with compendium.